CNCR vs. PPH ETF Comparison

Comparison of Loncar Cancer Immunotherapy ETF (CNCR) to Market Vectors Pharmaceutical ETF (PPH)
CNCR

Loncar Cancer Immunotherapy ETF

CNCR Description

ETF Series Solutions - Loncar Cancer Immunotherapy ETF is an exchange traded fund launched by ETF Series Solutions. The fund is co-managed by Exchange Traded Concepts, LLC and Vident Investment Advisory, LLC. It invests in public equity markets of the United States. The fund invests in stocks of companies operating in the pharmaceutical or biotechnology sectors, including those companies identified as having a high strategic focus on the development of drugs that harness the body's own immune system to fight cancer. It invests in stocks of companies across all market capitalizations. The fund seeks to replicate the performance of the Loncar Cancer Immunotherapy Index, by investing in stocks of companies as per their weightings in the index. ETF Series Solutions - Loncar Cancer Immunotherapy ETF is domiciled in the United States.

Grade (RS Rating)

Last Trade

$16.62

Average Daily Volume

39,506

Number of Holdings *

73

* may have additional holdings in another (foreign) market
PPH

Market Vectors Pharmaceutical ETF

PPH Description The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the Market Vectors US Listed Pharmaceutical 25 Index (the "Pharmaceutical Index"). The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Pharmaceutical Index is comprised of common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.

Grade (RS Rating)

Last Trade

$90.70

Average Daily Volume

133,775

Number of Holdings *

23

* may have additional holdings in another (foreign) market
Performance
Period CNCR PPH
30 Days -6.26% 0.64%
60 Days 18.80% 6.84%
90 Days 23.39% 11.47%
12 Months 36.45% 20.34%
2 Overlapping Holdings
Symbol Grade Weight in CNCR Weight in PPH Overlap
BMY D 0.79% 4.4% 0.79%
MRK C 1.05% 5.94% 1.05%
CNCR Overweight 71 Positions Relative to PPH
Symbol Grade Weight
JANX C 3.67%
YMAB C 3.09%
MRSN D 3.08%
FATE C 3.07%
MGNX D 3.0%
IOVA C 2.65%
RVMD C 2.37%
MOR A 2.04%
AUTL C 1.98%
ACLX C 1.98%
KURA C 1.96%
KYMR C 1.95%
SWTX C 1.78%
MRUS C 1.75%
SMMT D 1.73%
ARVN D 1.62%
BPMC C 1.62%
NUVB C 1.57%
NUVL D 1.53%
INBX D 1.52%
CGEM C 1.49%
IDYA D 1.42%
PRLD C 1.38%
GERN C 1.37%
NRIX C 1.34%
IGMS D 1.26%
SNDX C 1.2%
GLUE C 1.15%
BCYC C 1.13%
RXRX D 1.13%
TSVT D 1.12%
LYEL F 1.1%
ACET F 1.09%
NGM D 1.08%
IMCR D 1.07%
KPTI D 1.07%
HCM C 1.07%
REGN B 1.07%
DCPH D 1.05%
TYRA D 1.03%
BMEA F 1.02%
ELVN D 1.02%
ALLO D 1.02%
EXEL B 1.0%
XNCR C 1.0%
DAWN C 0.98%
PGEN D 0.93%
FHTX C 0.92%
IMTX D 0.85%
ITOS D 0.84%
AURA D 0.83%
CRBU F 0.82%
STRO F 0.81%
LEGN D 0.8%
RLAY F 0.78%
VOR F 0.77%
SDGR F 0.76%
ERAS D 0.76%
RCUS D 0.76%
IPHA F 0.75%
BNTX F 0.74%
GMAB D 0.71%
ACRV D 0.55%
DNA F 0.54%
ZNTL D 0.53%
RPTX F 0.46%
REPL D 0.42%
RAPT F 0.4%
AGEN F 0.39%
IMRX F 0.31%
GNLX F 0.24%
CNCR Underweight 21 Positions Relative to PPH
Symbol Grade Weight
LLY B -11.83%
NVO C -9.6%
JNJ F -6.65%
ABBV C -6.04%
AZN C -5.1%
NVS F -4.76%
MCK B -4.59%
SNY F -4.56%
HLN C -4.55%
PFE D -4.55%
GSK C -4.49%
TAK F -4.44%
ZTS F -4.16%
TEVA A -2.8%
VTRS D -1.86%
JAZZ D -1.12%
ELAN C -0.93%
CTLT C -0.93%
PRGO D -0.63%
OGN C -0.56%
PDCO D -0.32%
Compare ETFs